Sara Austin is a Neurology physician affiliated with The University of Texas at Austin. OpenAlex indexes 15 publications with 287 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
711 W 38th St
Suite F1
Austin, TX 787051121
Telephone
512-637-5854Registry record last updated 2 Jan 2014.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SK Life Science, Inc.Program year20251 payment
- Biogen, Inc.Program year20243 payments
- ARGENX US, INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
71.1%Gabapentinoids42%Gabapentin66%Pregabalin34%Part D≥62 patientsCholinesterase Inhibitor9.1%Pyridostigmine Bromide72%Donepezil Hcl28%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
10.6%Corticosteroid10.6%Prednisone100%Part D≥24 patientsMusculoskeletal
7.9%gamma-Aminobutyric Acid-ergic Agonist5.7%Baclofen100%Part D≥13 patientsSurvival of Motor Neuron 2 Splicing Modifier2.3%Evrysdi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Automatic detection of ALS from single-trial MEG signals during speech tasks: a pilot study
Frontiers in Psychology
2024 - Measuring Articulatory Patterns in Amyotrophic Lateral Sclerosis Using a Data-Driven Articulatory Consonant Distinctiveness Space Approach
Journal of Speech Language and Hearing Research
2023 - Tongue and Lip Acceleration as a Measure of Speech Decline in Amyotrophic Lateral Sclerosis
Folia Phoniatrica et Logopaedica
2022 - Voice Onset Time in Early- and Late-Stage Amyotrophic Lateral Sclerosis
Journal of Speech Language and Hearing Research
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Warach, MD, PhD
The University of Texas at Austin
Elizabeth Matsui, MD
The University of Texas at Austin
Jorge Almeida, MD
The University of Texas at Austin
George Rodgers, MD
The University of Texas at Austin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”